Tussigon

   
Google
 
Web NewDrugInformation.com

Tussigon


Drug - Tussigon
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Homatropine Methylbromide; Hydrocodone Bitartrate
Multiple ingredients are in alphabetical order.

Strength - 1.5MG;5MG
The potency of the active ingredient(s), Homatropine Methylbromide; Hydrocodone Bitartrate. May repeat for multiple part products.

Applicant - JONES PHARMA
The firm name holding legal responsibility for Tussigon. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088508
The FDA assigned number to Tussigon. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Tussigon. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AA
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 30, 1985
The date Tussigon was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tussigon. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tussigon is in. Format is RX, OTC, DISCN.

Applicant Full Name - Jones Pharma Inc Sub King Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Tussigon.

Tussigon